Trials / Conditions / Immunologic Deficiency Syndromes

Immunologic Deficiency Syndromes

18 registered clinical trials studyying Immunologic Deficiency Syndromes — 3 currently recruiting.

Status	Trial	Sponsor	Phase
Completed	Efficacy and Tolerability of ABBC1 in Volunteers Receiving the Influenza or Covid-19 Vaccine NCT04798677	AB Biotek	N/A
Recruiting	Sequential Transplantation of UCBSCs and Islet Cells in Children and Adolescents With Monogenic Immunodeficien NCT03835312	Children's Hospital of Fudan University	N/A
Enrolling By Invitation	Strimvelis Registry Study to Follow-up Patients With Adenosine Deaminase Severe Combined Immunodeficiency (ADA NCT03478670	Fondazione Telethon	—
Unknown	Retrospective Non-interventional Analysis of Opportunistic Infections in Immunocompromised and Frail Patients NCT03920735	University Hospital, Strasbourg, France	—
Completed	Study of Immune Globulin Intravenous (Human) GC5107 in Subjects With Primary Humoral Immunodeficiency NCT02783482	Green Cross Corporation	Phase 3
Completed	Novel Mechanisms and Approaches to Treat Neonatal Sepsis NCT02554630	University of Florida	—
Recruiting	Genetic Study of Immunodeficiency: Search for New Genetic Causes for Primary Immunodeficiencies NCT02735824	University Children's Hospital, Zurich	—
Completed	Effects of Orally Administered Beta-glucan on Leukocyte Function in Humans NCT01727895	Radboud University Medical Center	N/A
Completed	Feasibility of Measuring Immune Resp, Activation in Foreskin/Mucosa in HIV-, Uncircumcised High-HIV-risk MSM, NCT02630082	National Institute of Allergy and Infectious Diseases (NIAID)	N/A
Terminated	Efficacy, Safety and Kinetics Study of Octagam 10% in Primary Immunodeficiency Diseases NCT00811174	Octapharma	Phase 3
Completed	A Clinical Study of Intravenous Immunoglobulin NCT00468273	FFF Enterprises	Phase 3
Completed	ADA Gene Transfer Into Hematopoietic Stem/Progenitor Cells for the Treatment of ADA-SCID NCT00598481	Fondazione Telethon	Phase 2
Completed	Stem Cell Transplant for Immunologic or Histiocytic Disorders NCT00176865	Masonic Cancer Center, University of Minnesota	Phase 2
Terminated	Allogeneic Bone Marrow Transplantation in Patients With Primary Immunodeficiencies NCT00006054	Fairview University Medical Center	N/A
Completed	Voriconazole vs. Amphotericin B in the Treatment of Invasive Aspergillosis NCT00001646	National Institute of Allergy and Infectious Diseases (NIAID)	Phase 3
Completed	Randomized Study of Two Doses of Oral Valacyclovir in Immunocompromised Patients With Uncomplicated Herpes Zos NCT00006131	National Center for Research Resources (NCRR)	N/A
Completed	A Pilot Study of the Combination of Retinoic Acid and Interferon-Alpha2a for the Treatment of Lymphoproliferat NCT00001438	National Cancer Institute (NCI)	Phase 2
Completed	Studies of the Immune Response in Normal Subjects and Patients With Disorders of the Immune System NCT00001158	National Cancer Institute (NCI)	—